<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 3.3e -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: 5barz_2012sept30xbrl.xfr; Date: 2012/11/19T21:05:31 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80020001 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:us-roles="http://fasb.org/us-roles/2012-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:BARZOB="http://5barz.com/20120930">
    <link:schemaRef xlink:href="barzob-20120930.xsd" xlink:type="simple" />
    <xbrli:context id="From2012-01-01to2012-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_SubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:SubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-12-01to2008-12-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-12-01</xbrli:startDate>
        <xbrli:endDate>2008-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-11-01to2010-11-30_StockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BARZOB:StockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-11-01</xbrli:startDate>
        <xbrli:endDate>2010-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-12-01to2010-12-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-12-01</xbrli:startDate>
        <xbrli:endDate>2010-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-11-17_FoundersSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BARZOB:FoundersSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-11-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-03-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-03-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2011-06-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2011-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-07-01to2011-09-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-07-01</xbrli:startDate>
        <xbrli:endDate>2011-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-12-01to2012-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-12-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-12-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-10-01to2011-12-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-10-01</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-30_MinimumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-30_MaximumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-09-30_MinimumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-09-30_MaximumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31_MinimumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31_MaximumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_MinimumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_MaximumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-03-01to2012-03-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-03-01</xbrli:startDate>
        <xbrli:endDate>2012-03-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_Note1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:Note1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_Note2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:Note2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_Note3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:Note3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_Note1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:Note1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_Note2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:Note2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_Note3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:Note3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_StockOptionsRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">BARZOB:StockOptionsRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_StockOptionsRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">BARZOB:StockOptionsRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_StockOptionsRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">BARZOB:StockOptionsRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_StockOptionsRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">BARZOB:StockOptionsRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_StockOptionsRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">BARZOB:StockOptionsRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_StockOptionsRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">BARZOB:StockOptionsRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-29_NetBookValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">BARZOB:NetBookValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-29_AdjustmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">BARZOB:AdjustmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-29_ValuationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">BARZOB:ValuationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-10-01to2011-10-06_SubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:SubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-10-01</xbrli:startDate>
        <xbrli:endDate>2011-10-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_SubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:SubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-10-01to2012-10-12_CashMember_SubsequentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">BARZOB:SubsequentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-10-01</xbrli:startDate>
        <xbrli:endDate>2012-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-10-13to2012-10-26_CashMember_SubsequentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">BARZOB:SubsequentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-10-13</xbrli:startDate>
        <xbrli:endDate>2012-10-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-10-12_CashMember_SubsequentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">BARZOB:SubsequentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-10-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-10-26_CashMember_SubsequentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">BARZOB:SubsequentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-10-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-04-01to2012-04-13_CellynxGroupIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BARZOB:CellynxGroupIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-04-01</xbrli:startDate>
        <xbrli:endDate>2012-04-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-05-01to2012-05-15_CellynxGroupIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BARZOB:CellynxGroupIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-05-01</xbrli:startDate>
        <xbrli:endDate>2012-05-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-03-01to2012-03-29_CommonStockForCellynxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BARZOB:CommonStockForCellynxMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-03-01</xbrli:startDate>
        <xbrli:endDate>2012-03-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-10-01to2011-12-31_ConversionOfConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BARZOB:ConversionOfConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-10-01</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-03-31_GoodsAndServicesExchangedForEquityInstrumentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31_ConversionOfConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BARZOB:ConversionOfConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_GoodsAndServicesExchangedForEquityInstrumentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-11-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-11-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_MinimumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_MaximumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-04-01to2012-06-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-04-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-04-01to2012-06-30_GoodsAndServicesExchangedForEquityInstrumentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-04-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_CellynxNote1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:CellynxNote1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_CellynxNote2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:CellynxNote2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_CellynxNote1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:CellynxNote1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_CellynxNote2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:CellynxNote2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_StockOptionsRange.0006Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">BARZOB:StockOptionsRange.0006Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_StockOptionsRange.0006Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">BARZOB:StockOptionsRange.0006Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-11-14to2012-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-11-14</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-07-01to2012-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-07-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-07-01to2011-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-07-01</xbrli:startDate>
        <xbrli:endDate>2011-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-11-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-11-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_Note4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:Note4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_Note4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BARZOB:Note4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-06-30_MinimumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-06-30_MaximumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-06-30_MinimumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-06-30_MaximumMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-07-01to2012-09-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-07-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-07-01to2012-09-30_SubsidiariesMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:SubsidiariesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-07-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-04-01to2012-06-30_SubsidiariesMember_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:SubsidiariesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-04-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_DebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtSecurityAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-07-01to2012-09-30_DebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtSecurityAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-07-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-01-31_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-07-09_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-07-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-07-01to2012-07-09_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-07-01</xbrli:startDate>
        <xbrli:endDate>2012-07-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-03-31_CellynxGroupIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BARZOB:CellynxGroupIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-29_CellynxGroupIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BARZOB:CellynxGroupIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30_NotesPayableOtherPayablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001454124</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2012-01-01to2012-09-30">5Barz International, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2012-01-01to2012-09-30">0001454124</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2012-01-01to2012-09-30">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2012-01-01to2012-09-30">2012-09-30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2012-01-01to2012-09-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2012-01-01to2012-09-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2012-01-01to2012-09-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2012-01-01to2012-09-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2012-01-01to2012-09-30">No</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2012-01-01to2012-09-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2012-01-01to2012-09-30">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2012-01-01to2012-09-30">2012</dei:DocumentFiscalYearFocus>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2012-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2011-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2008-11-17_FoundersSharesMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2008-12-31_CommonStockMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2012-03-31_AdditionalPaidInCapitalMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1 contextRef="From2012-01-01to2012-09-30_SubsidiariesMember">2011-11-06</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1 contextRef="From2012-01-01to2012-03-31_CellynxGroupIncMember">2012-03-29</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2012-09-30_SubsidiariesMember" unitRef="Pure" decimals="INF">0.946</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2012-03-29_CellynxGroupIncMember" unitRef="Pure" decimals="INF">0.60</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <BARZOB:RecipocalHolding contextRef="From2012-01-01to2012-03-31_CellynxGroupIncMember" unitRef="Pure" decimals="INF">0.087</BARZOB:RecipocalHolding>
    <us-gaap:BusinessAcquisitionPreexistingRelationshipDescription contextRef="From2012-01-01to2012-03-31_CellynxGroupIncMember">CeLlynx Inc.</us-gaap:BusinessAcquisitionPreexistingRelationshipDescription>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction contextRef="From2012-01-01to2012-03-31_CellynxGroupIncMember" unitRef="Pure" decimals="INF">1.00</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">9559</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">468</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:Depreciation contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">1451</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">416</us-gaap:Depreciation>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">2239984</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1883650</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2012-09-30_PatentsMember" unitRef="USD" decimals="0">2001493</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2011-12-31_PatentsMember" unitRef="USD" decimals="0">1685867</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2012-09-30_TrademarksMember" unitRef="USD" decimals="0">234277</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2011-12-31_TrademarksMember" unitRef="USD" decimals="0">197783</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2012-09-30_LicensingAgreementsMember" unitRef="USD" decimals="0">4214</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2011-12-31_LicensingAgreementsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">7597</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2011-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">2232</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1883650</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2012-01-01to2012-09-30_MaximumMember">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2012-01-01to2012-09-30_MinimumMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2011-03-30_MinimumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2011-03-30_MaximumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2011-09-30_MinimumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">.20</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2011-09-30_MaximumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2011-12-31_MinimumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">0.1</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2011-12-31_MaximumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">0.15</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-03-31_MinimumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">0.10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-03-31_MaximumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">0.15</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-10-12_CashMember_SubsequentMember" unitRef="USDPShares" decimals="INF">0.05</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-10-26_CashMember_SubsequentMember" unitRef="USDPShares" decimals="INF">0.05</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-03-31_AdditionalPaidInCapitalMember" unitRef="USDPShares" decimals="INF">3.26</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2011-12-31_ConversionOfConvertibleDebentureMember" unitRef="USDPShares" decimals="INF">0.20</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-03-31_GoodsAndServicesExchangedForEquityInstrumentMember" unitRef="USDPShares" decimals="INF">0.10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-09-30_MinimumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">0.03</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-09-30_MaximumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">0.20</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2011-06-30_MinimumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">0.70</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2011-06-30_MaximumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-06-30_MinimumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">0.08</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2012-06-30_MaximumMember_CommonStockMember" unitRef="USDPShares" decimals="INF">0.15</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2008-12-01to2008-12-31_CommonStockMember" unitRef="Shares" decimals="INF">1776100</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2011-01-01to2011-03-30_CommonStockMember" unitRef="Shares" decimals="INF">650000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2011-04-01to2011-06-30_CommonStockMember" unitRef="Shares" decimals="INF">575500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2011-07-01to2011-09-30_CommonStockMember" unitRef="Shares" decimals="INF">134610</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2011-12-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="Shares" decimals="INF">78000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2011-10-01to2011-12-31_CommonStockMember" unitRef="Shares" decimals="INF">1080180</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2012-01-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">2136667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2012-10-01to2012-10-12_CashMember_SubsequentMember" unitRef="Shares" decimals="INF">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2012-10-13to2012-10-26_CashMember_SubsequentMember" unitRef="Shares" decimals="INF">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2012-04-01to2012-06-30_CommonStockMember" unitRef="Shares" decimals="INF">2936667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2012-07-01to2012-09-30_SubsidiariesMember_CommonStockMember" unitRef="Shares" decimals="INF">12000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2012-04-01to2012-06-30_SubsidiariesMember_CommonStockMember" unitRef="Shares" decimals="INF">2000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2012-10-01to2012-10-12_CashMember_SubsequentMember" unitRef="USD" decimals="0">15000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2012-10-13to2012-10-26_CashMember_SubsequentMember" unitRef="USD" decimals="0">5000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2012-01-01to2012-03-31_GoodsAndServicesExchangedForEquityInstrumentMember" unitRef="USD" decimals="0">155000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2012-04-01to2012-06-30_GoodsAndServicesExchangedForEquityInstrumentMember" unitRef="USD" decimals="0">267932</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2012-07-01to2012-09-30_CommonStockMember" unitRef="USD" decimals="0">122000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2010-12-01to2010-12-31_CommonStockMember" unitRef="Shares" decimals="INF">15600000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2012-01-01to2012-03-31_CellynxGroupIncMember" unitRef="Shares" decimals="INF">9000000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid contextRef="AsOf2012-03-29" unitRef="USD" decimals="0">170000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid>
    <us-gaap:BusinessAcquisitionNameOfAcquiredEntity contextRef="From2012-01-01to2012-03-31_CellynxGroupIncMember">Cellynx Group, Inc.</us-gaap:BusinessAcquisitionNameOfAcquiredEntity>
    <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1 contextRef="From2012-01-01to2012-03-31_CellynxGroupIncMember">2012-03-29</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
    <us-gaap:AcquisitionCosts contextRef="From2012-01-01to2012-03-31_CellynxGroupIncMember" unitRef="USD" decimals="0">1800000</us-gaap:AcquisitionCosts>
    <us-gaap:LineOfCreditFacilityMaximumMonthendOutstandingAmount contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">668844</us-gaap:LineOfCreditFacilityMaximumMonthendOutstandingAmount>
    <us-gaap:LineOfCreditFacilityCovenantTerms contextRef="From2012-01-01to2012-09-30">10/5/2013</us-gaap:LineOfCreditFacilityCovenantTerms>
    <BARZOB:VariableConversionRateperShare contextRef="From2012-01-01to2012-09-30" id="Foot-00-0">25%</BARZOB:VariableConversionRateperShare>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">139200</us-gaap:DebtConversionOriginalDebtAmount1>
    <BARZOB:DebtConversionConvertedInstrumentSharesReceived contextRef="From2012-01-01to2012-09-30" unitRef="Shares" decimals="INF">854745971</BARZOB:DebtConversionConvertedInstrumentSharesReceived>
    <us-gaap:RevenueRecognitionServicesRoyaltyFees contextRef="From2012-01-01to2012-03-31_CellynxGroupIncMember" id="Foot-01-0">50%</us-gaap:RevenueRecognitionServicesRoyaltyFees>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2012-09-30_Note1Member" unitRef="USD" decimals="0">42500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2012-09-30_Note2Member" unitRef="USD" decimals="0">37500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2012-09-30_Note3Member" unitRef="USD" decimals="0">42500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2012-09-30_CellynxNote1Member" unitRef="USD" decimals="0">37500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2012-09-30_CellynxNote2Member" unitRef="USD" decimals="0">12500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2012-09-30_Note4Member" unitRef="USD" decimals="0">135200</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2012-09-30_DebtSecuritiesMember" unitRef="USD" decimals="0">12000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2012-01-01to2012-09-30_Note1Member">2012-06-22</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2012-01-01to2012-09-30_Note2Member">2012-11-29</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2012-01-01to2012-09-30_Note3Member">2013-02-03</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2012-01-01to2012-09-30_CellynxNote1Member">2013-02-18</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2012-01-01to2012-09-30_CellynxNote2Member">2013-06-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2012-01-01to2012-09-30_Note4Member">2013-03-17</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="AsOf2012-09-30_Note1Member" unitRef="Pure" decimals="INF">0.08</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="AsOf2012-09-30_Note2Member" unitRef="Pure" decimals="INF">0.08</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="AsOf2012-09-30_Note3Member" unitRef="Pure" decimals="INF">0.08</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="AsOf2012-09-30_CellynxNote1Member" unitRef="Pure" decimals="INF">0.08</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="AsOf2012-09-30_CellynxNote2Member" unitRef="Pure" decimals="INF">0.08</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="AsOf2012-09-30_Note4Member" unitRef="Pure" decimals="INF">0.08</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="AsOf2012-09-30_DebtSecuritiesMember" unitRef="Pure" decimals="INF">0.10</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="AsOf2012-07-09_ConvertibleDebtMember" unitRef="Pure" decimals="INF">0.08</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2012-01-01to2012-09-30_StockOptionsRangeOneMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2012-01-01to2012-09-30_StockOptionsRangeTwoMember" unitRef="USDPShares" decimals="INF">0.10</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2012-01-01to2012-09-30_StockOptionsRangeThreeMember" unitRef="USDPShares" decimals="INF">0.26</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2012-01-01to2012-09-30_StockOptionsRange.0006Member" unitRef="USDPShares" decimals="INF">0.0006</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2012-01-01to2012-09-30_StockOptionsRangeOneMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2012-01-01to2012-09-30_StockOptionsRangeTwoMember" unitRef="USDPShares" decimals="INF">0.25</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2012-01-01to2012-09-30_StockOptionsRangeThreeMember" unitRef="USDPShares" decimals="INF">4.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2012-01-01to2012-09-30_StockOptionsRange.0006Member" unitRef="USDPShares" decimals="INF">0.0006</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2012-09-30" unitRef="Shares" decimals="INF">38554757</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2012-09-30_StockOptionsRangeOneMember" unitRef="Shares" decimals="INF">2500000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2012-09-30_StockOptionsRangeTwoMember" unitRef="Shares" decimals="INF">21554757</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2012-09-30_StockOptionsRangeThreeMember" unitRef="Shares" decimals="INF">2000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2012-09-30_StockOptionsRange.0006Member" unitRef="Shares" decimals="INF">12500000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2012-09-30_StockOptionsRangeOneMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2012-09-30_StockOptionsRangeTwoMember" unitRef="USDPShares" decimals="INF">0.17</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2012-09-30_StockOptionsRangeThreeMember" unitRef="USDPShares" decimals="INF">2.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2012-09-30_StockOptionsRange.0006Member" unitRef="USDPShares" decimals="INF">0.0006</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2012-01-01to2012-09-30_StockOptionsRangeOneMember">P2Y4M4D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2012-01-01to2012-09-30_StockOptionsRangeTwoMember">P0Y2M0D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2012-01-01to2012-09-30_StockOptionsRangeThreeMember">P0Y1M7D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2012-01-01to2012-09-30_StockOptionsRange.0006Member">P4Y7M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2012-01-01to2012-09-30_Note1Member" unitRef="USD" decimals="2">65361.52</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2012-01-01to2012-09-30_Note2Member" unitRef="USD" decimals="2">12000.00</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="AsOf2012-03-29" unitRef="USD" decimals="0">250000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent contextRef="AsOf2012-03-29" unitRef="USD" decimals="0">455000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="From2012-03-01to2012-03-29" unitRef="Shares" decimals="INF">1250000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice contextRef="AsOf2012-03-29" unitRef="USDPShares" decimals="INF">0.20</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssets contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">3260</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssets>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssets contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">3260</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssets>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">44718</us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">44718</us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">1800000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">1800000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">2113</us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">2113</us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">1735112</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">1735112</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationNotesPayableAndLongTermDebt contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">368411</us-gaap:BusinessAcquisitionPurchasePriceAllocationNotesPayableAndLongTermDebt>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationNotesPayableAndLongTermDebt contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">368411</us-gaap:BusinessAcquisitionPurchasePriceAllocationNotesPayableAndLongTermDebt>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherLiabilities contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">5856633</us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherLiabilities>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherLiabilities contextRef="AsOf2012-03-29_AdjustmentsMember" unitRef="USD" decimals="0">-5621027</us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherLiabilities>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherLiabilities contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">235606</us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherLiabilities>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">514745</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities contextRef="AsOf2012-03-29_AdjustmentsMember" unitRef="USD" decimals="0">-514745</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">-6624810</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet contextRef="AsOf2012-03-29_AdjustmentsMember" unitRef="USD" decimals="0">-6135772</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">-489038</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">1364038</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice contextRef="AsOf2012-03-29" unitRef="USD" decimals="0">875000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice contextRef="AsOf2012-03-29_NetBookValueMember" unitRef="USD" decimals="0">875000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice contextRef="AsOf2012-03-29_ValuationMember" unitRef="USD" decimals="0">875000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions contextRef="From2011-10-01to2011-10-06_SubsidiariesMember" unitRef="Shares" decimals="INF">10000000</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions>
    <BARZOB:SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssued contextRef="From2011-10-01to2011-10-06_SubsidiariesMember" unitRef="Shares" decimals="INF">5100000</BARZOB:SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssued>
    <BARZOB:SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssued contextRef="From2012-01-01to2012-09-30_SubsidiariesMember" unitRef="Shares" decimals="INF">9458000</BARZOB:SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssued>
    <BARZOB:SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesInEscrow contextRef="From2011-10-01to2011-10-06_SubsidiariesMember" unitRef="Shares" decimals="INF">4450000</BARZOB:SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesInEscrow>
    <BARZOB:BarzAgCommonStockParValue contextRef="From2011-10-01to2011-10-06_SubsidiariesMember">0.01 CHF</BARZOB:BarzAgCommonStockParValue>
    <BARZOB:BarzAgCommonStockParValue contextRef="From2012-01-01to2012-09-30_SubsidiariesMember">0.01 CHF</BARZOB:BarzAgCommonStockParValue>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2012-01-01to2012-09-30_SubsidiariesMember" unitRef="Shares" decimals="INF">71000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2011-10-01to2011-10-06_SubsidiariesMember" unitRef="USD" decimals="0">108752</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2012-01-01to2012-09-30_SubsidiariesMember" unitRef="USD" decimals="0">223650</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:RelatedPartyTransactionDate contextRef="From2012-01-01to2012-09-30">2010-12-30</us-gaap:RelatedPartyTransactionDate>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">370000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <BARZOB:IssuanceOfCommonStockToOfficer contextRef="From2012-01-01to2012-09-30" unitRef="Shares" decimals="INF">15600000</BARZOB:IssuanceOfCommonStockToOfficer>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">67494</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RelatedPartyTransactionRate contextRef="From2012-01-01to2012-09-30" unitRef="Pure" decimals="INF">0.05</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:InterestExpenseRelatedParty contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">115</us-gaap:InterestExpenseRelatedParty>
    <us-gaap:DueToRelatedPartiesNoncurrent contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">22825</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">79803</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:CommonStockSharesSubscribedButUnissued contextRef="AsOf2008-11-17_FoundersSharesMember" unitRef="Shares" decimals="INF">7100000</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio contextRef="From2010-11-01to2010-11-30_StockSplitMember" unitRef="Pure" decimals="INF">18</us-gaap:StockholdersEquityNoteStockSplitConversionRatio>
    <us-gaap:StockIssuedDuringPeriodSharesStockSplits contextRef="From2010-11-01to2010-11-30_StockSplitMember" unitRef="Shares" decimals="INF">250000000</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2010-12-01to2010-12-31_CommonStockMember" unitRef="Shares" decimals="INF">87800000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2011-01-01to2011-03-30_CommonStockMember" unitRef="USD" decimals="0">650000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2011-04-01to2011-06-30_CommonStockMember" unitRef="USD" decimals="0">553500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2011-07-01to2011-09-30_CommonStockMember" unitRef="USD" decimals="0">46500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2011-12-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">250380</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2011-10-01to2011-12-31_CommonStockMember" unitRef="USD" decimals="0">128018</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2012-01-01to2012-03-31_CommonStockMember" unitRef="USD" decimals="0">251500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2012-04-01to2012-06-30_CommonStockMember" unitRef="USD" decimals="0">39500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2012-07-01to2012-09-30_SubsidiariesMember_CommonStockMember" unitRef="USD" decimals="0">37800</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2012-04-01to2012-06-30_SubsidiariesMember_CommonStockMember" unitRef="USD" decimals="0">6300</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2012-01-01to2012-03-31_GoodsAndServicesExchangedForEquityInstrumentMember" unitRef="Shares" decimals="INF">1550000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2012-07-01to2012-09-30_CommonStockMember" unitRef="Shares" decimals="INF">2571388</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="From2011-10-01to2011-12-31_ConversionOfConvertibleDebentureMember" unitRef="Shares" decimals="INF">335695</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2011-10-01to2011-12-31_ConversionOfConvertibleDebentureMember" unitRef="USD" decimals="0">50000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <BARZOB:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationOptionsReceived contextRef="From2012-03-01to2012-03-29_CommonStockForCellynxMember" unitRef="Shares" decimals="INF">63412638</BARZOB:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationOptionsReceived>
    <BARZOB:StockIssuedDuringPeriodSharesBeforeStockSplits contextRef="From2010-11-01to2010-11-30_StockSplitMember" unitRef="Shares" decimals="INF">100000000</BARZOB:StockIssuedDuringPeriodSharesBeforeStockSplits>
    <us-gaap:SharePrice contextRef="AsOf2012-03-29_CellynxGroupIncMember" unitRef="USDPShares" decimals="INF">0.20</us-gaap:SharePrice>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2012-03-29_CellynxGroupIncMember" unitRef="USD" decimals="0">2200000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="AsOf2012-03-29_CellynxGroupIncMember" unitRef="USDPShares" decimals="INF">0.00015</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2012-11-15" unitRef="Shares" decimals="INF">110027456</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">14532</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">4653</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2012-09-30_FurnitureAndFixturesMember" unitRef="USD" decimals="0">9879</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2011-12-31_FurnitureAndFixturesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2012-09-30_ComputerEquipmentMember" unitRef="USD" decimals="0">4653</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2011-12-31_ComputerEquipmentMember" unitRef="USD" decimals="0">4653</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage contextRef="AsOf2012-09-30" unitRef="Pure" decimals="INF">0.586</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:DebtInstrumentIssuanceDate1 contextRef="From2012-01-01to2012-09-30_Note1Member">2011-09-20</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentIssuanceDate1 contextRef="From2012-01-01to2012-09-30_Note2Member">2012-02-27</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentIssuanceDate1 contextRef="From2012-01-01to2012-09-30_Note3Member">2012-05-03</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentIssuanceDate1 contextRef="From2012-01-01to2012-09-30_CellynxNote1Member">2012-05-24</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentIssuanceDate1 contextRef="From2012-01-01to2012-09-30_CellynxNote2Member">2012-09-18</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentIssuanceDate1 contextRef="From2012-01-01to2012-09-30_Note4Member">2012-09-18</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentIssuanceDate1 contextRef="From2012-07-01to2012-09-30_DebtSecuritiesMember">2012-08-14</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentMaturityDateRangeStart1 contextRef="From2012-01-01to2012-09-30_Note1Member">2012-03-20</us-gaap:DebtInstrumentMaturityDateRangeStart1>
    <us-gaap:DebtInstrumentMaturityDateRangeStart1 contextRef="From2012-01-01to2012-09-30_Note2Member">2012-09-10</us-gaap:DebtInstrumentMaturityDateRangeStart1>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">12000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">12000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">30618</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2012-09-30" unitRef="Shares" decimals="INF">32454757</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">42514757</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2012-01-01to2012-09-30" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="From2012-01-01to2012-09-30" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations contextRef="From2012-01-01to2012-09-30" unitRef="Shares" decimals="INF">10060000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2012-09-30" unitRef="USDPShares" decimals="INF">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2011-12-31" unitRef="USDPShares" decimals="INF">0.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2012-01-01to2012-09-30" unitRef="USDPShares" xsi:nil="true" />
    <BARZOB:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriodWeightedAverageFairValue contextRef="From2012-01-01to2012-09-30" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue contextRef="From2012-01-01to2012-09-30" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2012-01-01to2012-09-30">P0Y8M8D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue contextRef="AsOf2012-09-30" unitRef="USDPShares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2012-04-01to2012-04-13_CellynxGroupIncMember" unitRef="Shares" decimals="INF">51333333</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2012-05-01to2012-05-15_CellynxGroupIncMember" unitRef="Shares" decimals="INF">390000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:LongTermDebtDescription contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has the right to pre-pay the debt&#13;up to six months from the date of issue. During the first 120 days following the issue date of the Note may be settled by paying&#13;150% of the then-outstanding principal amount and any accrued and unpaid interest, penalties, or other amounts owing.&lt;/p&gt;</us-gaap:LongTermDebtDescription>
    <us-gaap:LongTermDebtDescription contextRef="From2012-03-01to2012-03-29_CommonStockForCellynxMember">&lt;p&gt;The valuation of the debt instrument with an embedded conversion feature is calculated at the face value of the debt instrument&#13;of $73,500 plus the intrinsic value attributable to the conversion of the debt instrument at a 75% discount to market, based&#13;upon the lowest 3 closing bid prices of the common stock for a period of 30 days prior to the date of conversions. That intrinsic&#13;valuation is calculated to be $ 381,500.&lt;/p&gt;</us-gaap:LongTermDebtDescription>
    <us-gaap:LongTermDebtDescription contextRef="From2012-01-01to2012-09-30_CellynxNote1Member">&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The terms of these note are such that subsequent to the prepayment&#13;        date six months after the issue date, if not paid,&amp;#160;holder may convert principal and unpaid interest on the note into shares&#13;        of the Company&amp;#146;s common stock, with the number of shares issuable determined to be the variable conversion factor. The variable&#13;        conversion factor is calculated by dividing the amount to be converted by the conversion price which is equal to 51% of the average&#13;        of the three lowest closing bid prices of the Company&amp;#146;s common stock over the ten trading days prior to the date of the conversion.&#13;        Holder is prohibited from converting amounts if principal and interest that would result in holder receiving shares, which when&#13;        combined with shares of the Company&amp;#146;s common stock held, would result in investor holding more than 4.99% of the Company&amp;#146;s&#13;        then- outstanding common stock. The shares of common stock, if any, issued upon conversion, will be restricted securities as defined&#13;        pursuant to the terms of Rule 144.&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:LongTermDebtDescription>
    <us-gaap:LongTermDebtDescription contextRef="From2012-01-01to2012-09-30_CellynxNote2Member">&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The terms of these note are such that subsequent to the prepayment&#13;        date six months after the issue date, if not paid,&amp;#160;holder may convert principal and unpaid interest on the note into shares&#13;        of the Company&amp;#146;s common stock, with the number of shares issuable determined to be the variable conversion factor. The variable&#13;        conversion factor is calculated by dividing the amount to be converted by the conversion price which is equal to 51% of the average&#13;        of the three lowest closing bid prices of the Company&amp;#146;s common stock over the ten trading days prior to the date of the conversion.&#13;        Holder is prohibited from converting amounts if principal and interest that would result in holder receiving shares, which when&#13;        combined with shares of the Company&amp;#146;s common stock held, would result in investor holding more than 4.99% of the Company&amp;#146;s&#13;        then- outstanding common stock. The shares of common stock, if any, issued upon conversion, will be restricted securities as defined&#13;        pursuant to the terms of Rule 144.&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:LongTermDebtDescription>
    <us-gaap:LongTermDebtDescription contextRef="From2012-01-01to2012-09-30_InvestorMember">&lt;p&gt;Convert the principal and unpaid interest into a certain number of shares, 180 days from the date of the agreement. The&#13;equity investment agreement provided to Holder the right, from time to time during the term of the Agreement, to invest in&#13;the Company through the purchase of up to $5,000,000 of the Company's Common Stock. Each purchase under this Agreement was&#13;to be made at 150% of the Volume Weighted Average Price (VWAP) on the day prior to the day the investment is made (the Purchase&#13;Price). Beginning on the date that is one hundred eighty (180) days following the Issue Date, Holder shall have the right&#13;to purchase Common Stock under this Agreement. Provided the VWAP is above $0.06, Holder shall purchase a minimum of $50,000&#13;per month beginning two hundred ten (210) days from the Issue Date.&lt;/p&gt;</us-gaap:LongTermDebtDescription>
    <us-gaap:LongTermDebtDescription contextRef="From2012-01-01to2012-09-30_NotesPayableOtherPayablesMember">&lt;p&gt;The Company may settle that note within the first 90 days following the issue date by paying to the Lender 140% of the&#13;principle amount of the note plus accrued interest. The Company may settle the note during the period which is 91 days from&#13;the issue date of the note to 180 days from the issue date of the note by payment of 150% of the principle amount of the note&#13;plus accrued interest. In the event that the note is not repaid 180 days from the date of issue, the note is convertible into&#13;common stock.&lt;/p&gt;</us-gaap:LongTermDebtDescription>
    <us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet contextRef="From2012-04-01to2012-04-13_CellynxGroupIncMember" unitRef="USD" decimals="0">7700</us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet>
    <us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet contextRef="From2012-05-01to2012-05-15_CellynxGroupIncMember" unitRef="USD" decimals="0">58500</us-gaap:DebtInstrumentIncreaseDecreaseForPeriodNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">50594</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">49209</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2010-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2011-09-30" unitRef="USD" decimals="0">1349</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2008-11-13" unitRef="USD" xsi:nil="true" />
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">21621</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">19159</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">72215</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">68368</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">4973</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">4185</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:NontradeReceivables contextRef="AsOf2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NontradeReceivables contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">250152</us-gaap:NontradeReceivables>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">170000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">2232387</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1883650</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">1364038</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2011-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherAssets contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">3596425</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">2303802</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">3673613</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">2376355</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">2244465</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">236446</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1196701</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:OtherLiabilities contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">52321</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">53033</us-gaap:OtherLiabilities>
    <us-gaap:ExtendedProductWarrantyAccrualCurrent contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">8562</us-gaap:ExtendedProductWarrantyAccrualCurrent>
    <us-gaap:ExtendedProductWarrantyAccrualCurrent contextRef="AsOf2011-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">22825</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">120437</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">491874</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="AsOf2011-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebt contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">621990</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">55318</us-gaap:LongTermDebt>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">3454037</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1661935</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">3454037</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1661935</us-gaap:Liabilities>
    <us-gaap:CommonStockValue contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">109627</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">90183</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">4651812</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1458086</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">2742718</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
    <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">834377</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
    <us-gaap:TreasuryStockValue contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">1800000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2011-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterest contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">855</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">528</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">219576</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">714420</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">3673613</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">2376355</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">12000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2011-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2012-09-30" unitRef="Shares" decimals="INF">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2012-09-30" unitRef="Shares" decimals="INF">109627456</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">90182785</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2012-09-30" unitRef="Shares" decimals="INF">109627456</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">90182785</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SalesRevenueGoodsGross contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:SalesRevenueGoodsGross contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:SalesRevenueGoodsGross contextRef="From2008-11-14to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:SalesRevenueGoodsGross contextRef="From2012-07-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:SalesRevenueGoodsGross contextRef="From2011-07-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2012-07-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2011-07-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DepreciationAndAmortization contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">2689</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">416</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">3742</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">831</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">236</us-gaap:DepreciationAndAmortization>
    <us-gaap:InterestAndDebtExpense contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">140880</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">14776</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">184277</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">2957</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">3899</us-gaap:InterestAndDebtExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">94635</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">162982</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">324376</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">7871</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">39284</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">1507354</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">402824</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">2088344</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">332404</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">102208</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">1745558</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">580998</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">2600739</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">344062</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">145627</us-gaap:OperatingExpenses>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">-1745558</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-580998</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-2600739</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">-344062</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">-145627</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:InterestAndOtherIncome contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">-1212</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-7538</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-17878</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">1128</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">-4419</us-gaap:InterestAndOtherIncome>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">75556</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">75556</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">147530</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="From2011-07-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">92288</us-gaap:DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts>
    <us-gaap:DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">92288</us-gaap:DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts>
    <us-gaap:DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">74623</us-gaap:DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts>
    <us-gaap:DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts contextRef="From2011-07-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ExtendedProductWarrantyAccrualPayments contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">2402</us-gaap:ExtendedProductWarrantyAccrualPayments>
    <us-gaap:ExtendedProductWarrantyAccrualPayments contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ExtendedProductWarrantyAccrualPayments contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">2402</us-gaap:ExtendedProductWarrantyAccrualPayments>
    <us-gaap:ExtendedProductWarrantyAccrualPayments contextRef="From2012-07-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ExtendedProductWarrantyAccrualPayments contextRef="From2011-07-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-781</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2012-07-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2011-07-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">1735</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-5051</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-2913</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">2054</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">-5052</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:MinorityInterestInNetIncomeLossOtherMinorityInterests contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">-684</us-gaap:MinorityInterestInNetIncomeLossOtherMinorityInterests>
    <us-gaap:MinorityInterestInNetIncomeLossOtherMinorityInterests contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestInNetIncomeLossOtherMinorityInterests contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-955</us-gaap:MinorityInterestInNetIncomeLossOtherMinorityInterests>
    <us-gaap:MinorityInterestInNetIncomeLossOtherMinorityInterests contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">-139</us-gaap:MinorityInterestInNetIncomeLossOtherMinorityInterests>
    <us-gaap:MinorityInterestInNetIncomeLossOtherMinorityInterests contextRef="From2011-07-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherExpenses contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">170084</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-12589</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">149280</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">225195</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">-9471</us-gaap:OtherExpenses>
    <us-gaap:NetIncomeLoss contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">-1915642</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-568409</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-2750019</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="0">-569258</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">-136156</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="From2012-01-01to2012-09-30" unitRef="USDPShares" decimals="INF">-0.0188</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2011-01-01to2011-09-30" unitRef="USDPShares" decimals="INF">-0.0064</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2012-07-01to2012-09-30" unitRef="USDPShares" decimals="INF">-0.0052</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2011-07-01to2011-09-30" unitRef="USDPShares" decimals="INF">-0.0015</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2012-01-01to2012-09-30" unitRef="Shares" decimals="INF">102081180</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2011-01-01to2011-09-30" unitRef="Shares" decimals="INF">88556147</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2012-07-01to2012-09-30" unitRef="Shares" decimals="INF">108607401</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2011-07-01to2011-09-30" unitRef="Shares" decimals="INF">88878906</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:DepreciationAmortizationAndAccretionNet contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">2689</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">416</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">3158</us-gaap:DepreciationAmortizationAndAccretionNet>
    <BARZOB:CommonSharesIssuedForServices contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">452990</BARZOB:CommonSharesIssuedForServices>
    <BARZOB:CommonSharesIssuedForServices contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <BARZOB:CommonSharesIssuedForServices contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">460490</BARZOB:CommonSharesIssuedForServices>
    <us-gaap:ServicingLiabilityAtFairValuePeriodIncreaseDecrease contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">491874</us-gaap:ServicingLiabilityAtFairValuePeriodIncreaseDecrease>
    <us-gaap:ServicingLiabilityAtFairValuePeriodIncreaseDecrease contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ServicingLiabilityAtFairValuePeriodIncreaseDecrease contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">491874</us-gaap:ServicingLiabilityAtFairValuePeriodIncreaseDecrease>
    <us-gaap:DebtIssuanceCosts contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">18868</us-gaap:DebtIssuanceCosts>
    <us-gaap:DebtIssuanceCosts contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtIssuanceCosts contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">18868</us-gaap:DebtIssuanceCosts>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">53033</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <BARZOB:UnpaidInterestIncome contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">-1212</BARZOB:UnpaidInterestIncome>
    <BARZOB:UnpaidInterestIncome contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-7538</BARZOB:UnpaidInterestIncome>
    <BARZOB:UnpaidInterestIncome contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-1212</BARZOB:UnpaidInterestIncome>
    <BARZOB:UnpaidInterestExpense contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">139223</BARZOB:UnpaidInterestExpense>
    <BARZOB:UnpaidInterestExpense contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">8147</BARZOB:UnpaidInterestExpense>
    <BARZOB:UnpaidInterestExpense contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">162056</BARZOB:UnpaidInterestExpense>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">-535142</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-430489</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-1068654</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInDeposits contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInDeposits contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-170000</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:IncreaseDecreaseInDeposits contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-170000</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-5572</us-gaap:PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease>
    <us-gaap:PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-4653</us-gaap:PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-175572</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-174653</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">126088</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">233500</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">376240</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:IncreaseDecreaseInNotesPayableCurrent contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInNotesPayableCurrent contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-292688</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
    <us-gaap:IncreaseDecreaseInNotesPayableCurrent contextRef="From2008-11-14to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquireOtherProductiveAssets contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquireOtherProductiveAssets contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">238915</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">242865</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">278500</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">110013</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">392139</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-324576</us-gaap:ProceedsFromRepaymentsOfNotesPayable>
    <BARZOB:ProceedsUsedToSettleNotesPayable contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">65362</BARZOB:ProceedsUsedToSettleNotesPayable>
    <BARZOB:ProceedsUsedToSettleNotesPayable contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <BARZOB:ProceedsUsedToSettleNotesPayable contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">65362</BARZOB:ProceedsUsedToSettleNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">358000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">1262500</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">1751306</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">79476</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">156101</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ShareholderLoansToFinanceLeveragedBuyout contextRef="From2012-01-01to2012-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareholderLoansToFinanceLeveragedBuyout contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareholderLoansToFinanceLeveragedBuyout contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">8602</us-gaap:ShareholderLoansToFinanceLeveragedBuyout>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">536526</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">607410</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">1293901</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">1384</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">1349</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">50594</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:InterestPaid contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">16800</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">4776</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">60197</us-gaap:InterestPaid>
    <us-gaap:DebtInstrumentIncreaseDecreaseOtherNet contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">-55247</us-gaap:DebtInstrumentIncreaseDecreaseOtherNet>
    <us-gaap:DebtInstrumentIncreaseDecreaseOtherNet contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtInstrumentIncreaseDecreaseOtherNet contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-55247</us-gaap:DebtInstrumentIncreaseDecreaseOtherNet>
    <us-gaap:MinorityInterestInNetIncomeLossOperatingPartnerships contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">-3878</us-gaap:MinorityInterestInNetIncomeLossOperatingPartnerships>
    <us-gaap:MinorityInterestInNetIncomeLossOperatingPartnerships contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestInNetIncomeLossOperatingPartnerships contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-4135</us-gaap:MinorityInterestInNetIncomeLossOperatingPartnerships>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">-97612</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">-8602</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-97612</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">369976</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2011-01-01to2011-09-30" unitRef="USD" decimals="0">145497</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">606422</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:ExtendedProductWarrantyAccrualPeriodIncreaseDecrease contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">5120</us-gaap:ExtendedProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ExtendedProductWarrantyAccrualPeriodIncreaseDecrease contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ExtendedProductWarrantyAccrualPeriodIncreaseDecrease contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">5120</us-gaap:ExtendedProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">2462</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">-16697</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <BARZOB:CommonStockIssuedOnAcquisitionOfCellynxGroupInc. contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">250000</BARZOB:CommonStockIssuedOnAcquisitionOfCellynxGroupInc.>
    <BARZOB:CommonStockIssuedOnAcquisitionOfCellynxGroupInc. contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <BARZOB:CommonStockIssuedOnAcquisitionOfCellynxGroupInc. contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">250000</BARZOB:CommonStockIssuedOnAcquisitionOfCellynxGroupInc.>
    <BARZOB:SettlementOfPrepaidDepositUponAcquisitionOfCellynxGroupInc. contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">170000</BARZOB:SettlementOfPrepaidDepositUponAcquisitionOfCellynxGroupInc.>
    <BARZOB:SettlementOfPrepaidDepositUponAcquisitionOfCellynxGroupInc. contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <BARZOB:SettlementOfPrepaidDepositUponAcquisitionOfCellynxGroupInc. contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">170000</BARZOB:SettlementOfPrepaidDepositUponAcquisitionOfCellynxGroupInc.>
    <BARZOB:FairMarketValueOfNotesConvertedUponAcquisitionOfCellynx contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">455000</BARZOB:FairMarketValueOfNotesConvertedUponAcquisitionOfCellynx>
    <BARZOB:FairMarketValueOfNotesConvertedUponAcquisitionOfCellynx contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <BARZOB:FairMarketValueOfNotesConvertedUponAcquisitionOfCellynx contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">455000</BARZOB:FairMarketValueOfNotesConvertedUponAcquisitionOfCellynx>
    <BARZOB:FairMarketValueOfNetAssetsAcquired contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">875000</BARZOB:FairMarketValueOfNetAssetsAcquired>
    <BARZOB:FairMarketValueOfNetAssetsAcquired contextRef="From2011-01-01to2011-09-30" unitRef="USD" xsi:nil="true" />
    <BARZOB:FairMarketValueOfNetAssetsAcquired contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">875000</BARZOB:FairMarketValueOfNetAssetsAcquired>
    <BARZOB:InvestmentInCellynxIntellectualPropertyForShares contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="0">1800000</BARZOB:InvestmentInCellynxIntellectualPropertyForShares>
    <BARZOB:InvestmentInCellynxIntellectualPropertyForShares contextRef="From2008-11-14to2012-09-30" unitRef="USD" decimals="0">1800000</BARZOB:InvestmentInCellynxIntellectualPropertyForShares>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 1 &amp;#150; Organization and basis of reporting&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font-size: 11pt"&gt;5Barz International,&#13;Inc. and its&amp;#146; consolidated subsidiaries is the owner of a proprietary technology for the wireless marketplace, branded as&#13;&lt;/font&gt;5BARz&amp;#153;&lt;font style="font-size: 11pt"&gt;. The Company provides innovative and affordable solutions, comprised of highly&#13;engineered devices, that improve poor mobile phone and wireless data signals for phones, laptops, and tablets. The Company&amp;#146;s&#13;developing product lines, reduce dropped calls, improve reception, and in many cases eliminate dead zones by improving wireless&#13;signal within the immediate vicinity of the user. &amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company was incorporated under the laws of the State of Nevada&#13;on November 17, 2008. At that time, the Company held certain technology related to bio-degradable product and operated under the&#13;name &amp;#147;Bio-Stuff&amp;#148;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On December 29, 2010 the Company changed its name to 5BARz International,&#13;Inc. and acquired a set of agreements to acquire from Cellynx Group, Inc. certain rights and intellectual property underlying the&#13;5BARz products, a highly engineered microcell technology referred to as a &amp;#147;cellular network infrastructure device&amp;#148;.&#13;The 5BARz device captures cell signal and provides a smart amplification and resend of that cell signal giving the user improved&#13;cellular reception in their home, office or while mobile. Pursuant to the agreements referred to above, the Company was engaged&#13;as the exclusive agent for the global sales and marketing of the 5BARz products. On March 29, 2012, 5Barz International, Inc. entered&#13;into an amendment agreement with Cellynx Group Inc. through which 5BARz acquired a 60% interest in the intellectual property referred&#13;to as the 5BARz technology, and acquired a 60% ownership interest in Cellynx Group, Inc. among other amendments (see Note 7).&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On November 6, 2011, the Company incorporated a subsidiary Company&#13;in Zurich, Switzerland called 5BARz AG which is a 94.6% held subsidiary at September 30, 2012. That entity has been licensed the&#13;marketing and distribution rights for 5BARz products in Germany, Austria and Switzerland.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On March 29, 2012, the Company acquired a 60% interest in the common&#13;stock of Cellynx Group, Inc., a Company which holds a 100% interest in Cellynx Inc. In conjunction with the asset purchase agreement&#13;completed on March 29, 2012, 5BARz International Inc. issued 9,000,000 shares representing an 8.7% reciprocal holding by Cellynx&#13;Group Inc. in 5Barz International Inc.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;These financial statements reflect the financial position for the&#13;Company and its subsidiary Companies 5BARz AG, Cellynx Group Inc. and its wholly owned subsidiary Cellynx Inc. as at September&#13;30, 2012. Results of operations for subsidiary Companies are reflected only from the date of acquisition of that subsidiary for&#13;the period indicated in the respective statement. &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;b&gt;&lt;u&gt;Going concern &lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;These financial statements have been prepared on a going concern&#13;basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font-size: 11pt"&gt;During the nine months ended September&#13;30, 2012, the Company was engaged in a business and had suffered losses from development stage activities to date. In addition,&#13;the Company has minimal operating funds. Although management is currently developing its sales and marketing program for the sales&#13;of &lt;/font&gt;5BARz&amp;#153;&lt;font style="font-size: 11pt"&gt; product, the Company has made no revenue to date.&amp;#160;&amp;#160;The Company is&#13;seeking additional sources of equity or debt financing, and there is no assurance these activities will be successful. These factors&#13;raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include&#13;any adjustments that might result from the outcome of this uncertainty.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Development stage &lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company has been in the development stage since its formation&#13;and has not yet realized any revenues from its planned operations.&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 2 - Summary of significant accounting policies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Basis of presentation&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The accompanying consolidated financial statements have been prepared&#13;in accordance with accounting principles generally accepted in the United States of America. The accompanying consolidated financial&#13;statements include the accounts of 5Barz International Inc., and its 94.6% owned subsidiary, 5Barz AG., and it&amp;#146;s 60% owned&#13;subsidiary Cellynx Group, Inc. and that Company&amp;#146;s 100% owned subsidiary Cellynx, Inc. All intercompany accounts and transactions&#13;have been eliminated upon consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Cash&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Cash and cash equivalents include cash in hand and cash in time&#13;deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Use of estimates&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The preparation of financial statements in conformity with accounting&#13;principles generally accepted in the United States of America requires management to make estimates and assumptions that affect&#13;the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial&#13;statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those&#13;estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Concentration of credit risk&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Cash includes deposits in accounts maintained at financial institutions.&amp;#160;&amp;#160;Certain&#13;financial instruments, which subject the Company to concentration of credit risk, consist of cash. The Company maintains balances&#13;at financial institutions which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for the banks&#13;located in the United States. As of September 30, 2012 and 2011, the Company did not have any deposits in excess of federally-insured&#13;limits.&amp;#160;&amp;#160;To date, the Company has not experienced any losses in such accounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Equipment&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Equipment is recorded at historical cost and is depreciated using&#13;the straight-line method over their estimated useful lives.&amp;#160;&amp;#160;The useful life and depreciation method are reviewed periodically&#13;to ensure that the depreciation method and period are consistent with the anticipated pattern of future economic benefits. Expenditures&#13;for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains and losses&#13;on disposals are included in the results of operations. The useful life of the equipment is being depreciated over three to five&#13;years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Intangible assets&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Acquired patents, licensing rights and trademarks are capitalized&#13;at their acquisition cost or fair value. The legal costs, patent registration fees, and models and drawings required for filing&#13;patent applications are capitalized if they relate to commercially viable technologies. Commercially viable technologies are those&#13;technologies that are projected to generate future positive cash flows in the near term. Legal costs associated with applications&#13;that are not determined to be commercially viable are expensed as incurred. All research and development costs incurred in developing&#13;the patentable idea are expensed as incurred. Legal fees from the costs incurred in successful defense to the extent of an evident&#13;increase in the value of the patents are capitalized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Capitalized costs for patents are amortized on a straight-line basis&#13;over the remaining twenty-year legal life of each patent after the costs have been incurred. Once each patent or trademark is issued,&#13;capitalized costs are amortized on a straight-line basis over a period not to exceed 20 years and 10 years, respectively. All research&#13;and development costs incurred in developing the patentable idea are expensed as incurred. The licensing right is amortized on&#13;a straight-line basis over a period of 10 years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Impairment or disposal of long-lived assets&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company applies the provisions of Accounting Standards Codification&#13;(&amp;#147;ASC&amp;#148;) Topic 360, &amp;#147;Property, Plant, and Equipment,&amp;#148; which addresses financial accounting and reporting&#13;for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used&#13;in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets&#13;are less than the assets&amp;#146;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;carrying amounts. In that event, a loss is recognized based on the&#13;amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of&#13;is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review, the Company&#13;believes that as of September 30, 2012 and 2011, there was no significant impairment of its long-lived assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Revenue recognition&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company's revenue recognition policies are in compliance with&#13;ASC Topic 605, &amp;#147;Revenue Recognition.&amp;#148;&amp;#160;&amp;#160;Revenue is recognized at the date of shipment to customers, and when&#13;the price is fixed or determinable, the delivery is completed, no other significant obligations of the Company exist and collectability&#13;is reasonably assured.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Foreign currency translation&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Transactions in foreign currencies have been translated into US&#13;dollars using the temporal method. Under this method, monetary assets and liabilities are translated at the year-end exchange rate.&#13;Non-monetary assets have been translated at the historical rate of exchange prevailing at the date of the transaction. Expenses&#13;have been translated at the exchange rate at the time of the transaction. Realized and unrealized foreign exchange gains and losses&#13;are included in operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Fair value of financial instruments&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;We have adopted Accounting Standards Codification regarding &lt;i&gt;Disclosure&#13;About Derivative Financial Instruments and Fair Value of Financial Instruments&lt;/i&gt;. The carrying amounts of cash, accounts payable,&#13;accrued expenses, and other current liabilities approximate fair value because of the short maturity of these items. These fair&#13;value estimates are subjective in nature and involve uncertainties and matters of significant judgment, and, therefore, cannot&#13;be determined with precision. Changes in assumptions could significantly affect these estimates.&amp;#160;&amp;#160;We do not hold or issue&#13;financial instruments for trading purposes, nor do we utilize derivative instruments in the management of foreign exchange, commodity&#13;price or interest rate market risks.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Accounting for Derivatives&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company evaluates its convertible instruments, options, warrants&#13;or other contracts to determine if those contracts or components of those contracts qualify as derivatives to be separately accounted&#13;for under ASC Topic 815, &amp;#147;Derivatives and Hedging&amp;#148;. The result of this accounting treatment is that the fair value&#13;of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is&#13;recorded as a liability, the change in fair value is recorded in the statement of operations as other income (expense). Upon conversion&#13;or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value&#13;is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under&#13;ASC Topic 815 are reclassified to liability at the fair value of the instrument on the reclassification date.&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;u&gt;Income taxes&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company accounts for income taxes in accordance with ASC Topic&#13;740, &amp;#147;Income Taxes.&amp;#148; ASC 740 requires a company to use the asset and liability method of accounting for income taxes,&#13;whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for&#13;taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities&#13;and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely&#13;than not that some portion, or all of, the deferred tax assets will&amp;#160;not be realized.&amp;#160;&amp;#160;Deferred tax assets and liabilities&#13;are adjusted for the effects of changes in tax laws and rates on the date of enactment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Under ASC 740, a tax position is recognized as a benefit only if&#13;it is &amp;#147;more likely than not&amp;#148; that the tax position would be sustained in a tax examination, with a tax examination&#13;being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized&#13;on examination. For tax positions not meeting the &amp;#147;more likely than not&amp;#148; test, no tax benefit is recorded. The adoption&#13;had no effect on the Company&amp;#146;s financial statements.&amp;#160;&amp;#160;Penalties and interest incurred related to underpayment of&#13;income tax are classified as income tax expense in the period incurred.&amp;#160;&amp;#160;No significant penalties or interest relating&#13;to income taxes have been incurred during the nine months ended September 30, 2012 and 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Net loss per share&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company reports loss per share in accordance with the ASC Topic&#13;260, &amp;#147;Earnings Per Share&amp;#148;&amp;#160;, which requires presentation of basic and diluted EPS on the face of the income statement&#13;for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS&#13;computation to the numerator and denominator of the diluted EPS computation.&amp;#160;&amp;#160;In the accompanying financial statements,&#13;basic earnings per share of common stock is computed by dividing net income by the weighted average number of shares of common&#13;stock outstanding during the period.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Recent accounting pronouncements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;In June 2011, the FASB issued new guidance on the presentation of&#13;comprehensive income that will require a company to present components of net income and other comprehensive income in one continuous&#13;statement or in two separate, but consecutive statements. There are no changes to the components that are recognized in net income&#13;or other comprehensive income under current GAAP. This guidance is effective for fiscal years, and interim periods within those&#13;fiscal years, beginning after December 15, 2011, with early adoption permitted.&amp;#160;&amp;#160;The Company is currently evaluating&#13;this guidance, but does not expect its adoption will have a material effect on its consolidated financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Basis of presentation&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The accompanying consolidated financial statements have been prepared&#13;in accordance with accounting principles generally accepted in the United States of America. The accompanying consolidated financial&#13;statements include the accounts of 5Barz International Inc., and its 94.6% owned subsidiary, 5Barz AG., and it&amp;#146;s 60% owned&#13;subsidiary Cellynx Group, Inc. and that Company&amp;#146;s 100% owned subsidiary Cellynx, Inc. All intercompany accounts and transactions&#13;have been eliminated upon consolidation.&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Cash&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Cash and cash equivalents include cash in hand and cash in time&#13;deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Use of estimates&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The preparation of financial statements in conformity with accounting&#13;principles generally accepted in the United States of America requires management to make estimates and assumptions that affect&#13;the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial&#13;statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those&#13;estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Concentration of credit risk&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Cash includes deposits in accounts maintained at financial institutions.&amp;#160;&amp;#160;Certain&#13;financial instruments, which subject the Company to concentration of credit risk, consist of cash. The Company maintains balances&#13;at financial institutions which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for the banks&#13;located in the United States. As of September 30, 2012 and 2011, the Company did not have any deposits in excess of federally-insured&#13;limits.&amp;#160;&amp;#160;To date, the Company has not experienced any losses in such accounts.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Equipment&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Equipment is recorded at historical cost and is depreciated using&#13;the straight-line method over their estimated useful lives.&amp;#160;&amp;#160;The useful life and depreciation method are reviewed periodically&#13;to ensure that the depreciation method and period are consistent with the anticipated pattern of future economic benefits. Expenditures&#13;for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains and losses&#13;on disposals are included in the results of operations. The useful life of the equipment is being depreciated over three to five&#13;years.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Intangible assets&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Acquired patents, licensing rights and trademarks are capitalized&#13;at their acquisition cost or fair value. The legal costs, patent registration fees, and models and drawings required for filing&#13;patent applications are capitalized if they relate to commercially viable technologies. Commercially viable technologies are those&#13;technologies that are projected to generate future positive cash flows in the near term. Legal costs associated with applications&#13;that are not determined to be commercially viable are expensed as incurred. All research and development costs incurred in developing&#13;the patentable idea are expensed as incurred. Legal fees from the costs incurred in successful defense to the extent of an evident&#13;increase in the value of the patents are capitalized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Capitalized costs for patents are amortized on a straight-line basis&#13;over the remaining twenty-year legal life of each patent after the costs have been incurred. Once each patent or trademark is issued,&#13;capitalized costs are amortized on a straight-line basis over a period not to exceed 20 years and 10 years, respectively. All research&#13;and development costs incurred in developing the patentable idea are expensed as incurred. The licensing right is amortized on&#13;a straight-line basis over a period of 10 years.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Impairment or disposal of long-lived assets&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company applies the provisions of Accounting Standards Codification&#13;(&amp;#147;ASC&amp;#148;) Topic 360, &amp;#147;Property, Plant, and Equipment,&amp;#148; which addresses financial accounting and reporting&#13;for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used&#13;in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets&#13;are less than the assets&amp;#146;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;carrying amounts. In that event, a loss is recognized based on the&#13;amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of&#13;is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review, the Company&#13;believes that as of September 30, 2012 and 2011, there was no significant impairment of its long-lived assets.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Revenue recognition&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company's revenue recognition policies are in compliance with&#13;ASC Topic 605, &amp;#147;Revenue Recognition.&amp;#148;&amp;#160;&amp;#160;Revenue is recognized at the date of shipment to customers, and when&#13;the price is fixed or determinable, the delivery is completed, no other significant obligations of the Company exist and collectability&#13;is reasonably assured.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Foreign currency translation&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Transactions in foreign currencies have been translated into US&#13;dollars using the temporal method. Under this method, monetary assets and liabilities are translated at the year-end exchange rate.&#13;Non-monetary assets have been translated at the historical rate of exchange prevailing at the date of the transaction. Expenses&#13;have been translated at the exchange rate at the time of the transaction. Realized and unrealized foreign exchange gains and losses&#13;are included in operations.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Fair value of financial instruments&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;We have adopted Accounting Standards Codification regarding &lt;i&gt;Disclosure&#13;About Derivative Financial Instruments and Fair Value of Financial Instruments&lt;/i&gt;. The carrying amounts of cash, accounts payable,&#13;accrued expenses, and other current liabilities approximate fair value because of the short maturity of these items. These fair&#13;value estimates are subjective in nature and involve uncertainties and matters of significant judgment, and, therefore, cannot&#13;be determined with precision. Changes in assumptions could significantly affect these estimates.&amp;#160;&amp;#160;We do not hold or issue&#13;financial instruments for trading purposes, nor do we utilize derivative instruments in the management of foreign exchange, commodity&#13;price or interest rate market risks.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Accounting for Derivatives&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company evaluates its convertible instruments, options, warrants&#13;or other contracts to determine if those contracts or components of those contracts qualify as derivatives to be separately accounted&#13;for under ASC Topic 815, &amp;#147;Derivatives and Hedging&amp;#148;. The result of this accounting treatment is that the fair value&#13;of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is&#13;recorded as a liability, the change in fair value is recorded in the statement of operations as other income (expense). Upon conversion&#13;or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value&#13;is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under&#13;ASC Topic 815 are reclassified to liability at the fair value of the instrument on the reclassification date.&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Income taxes&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company accounts for income taxes in accordance with ASC Topic&#13;740, &amp;#147;Income Taxes.&amp;#148; ASC 740 requires a company to use the asset and liability method of accounting for income taxes,&#13;whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for&#13;taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities&#13;and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely&#13;than not that some portion, or all of, the deferred tax assets will&amp;#160;not be realized.&amp;#160;&amp;#160;Deferred tax assets and liabilities&#13;are adjusted for the effects of changes in tax laws and rates on the date of enactment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Under ASC 740, a tax position is recognized as a benefit only if&#13;it is &amp;#147;more likely than not&amp;#148; that the tax position would be sustained in a tax examination, with a tax examination&#13;being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized&#13;on examination. For tax positions not meeting the &amp;#147;more likely than not&amp;#148; test, no tax benefit is recorded. The adoption&#13;had no effect on the Company&amp;#146;s financial statements.&amp;#160;&amp;#160;Penalties and interest incurred related to underpayment of&#13;income tax are classified as income tax expense in the period incurred.&amp;#160;&amp;#160;No significant penalties or interest relating&#13;to income taxes have been incurred during the nine months ended September 30, 2012 and 2011.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Net loss per share&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company reports loss per share in accordance with the ASC Topic&#13;260, &amp;#147;Earnings Per Share&amp;#148;&amp;#160;, which requires presentation of basic and diluted EPS on the face of the income statement&#13;for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS&#13;computation to the numerator and denominator of the diluted EPS computation.&amp;#160;&amp;#160;In the accompanying financial statements,&#13;basic earnings per share of common stock is computed by dividing net income by the weighted average number of shares of common&#13;stock outstanding during the period.&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Recent accounting pronouncements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;In June 2011, the FASB issued new guidance on the presentation of&#13;comprehensive income that will require a company to present components of net income and other comprehensive income in one continuous&#13;statement or in two separate, but consecutive statements. There are no changes to the components that are recognized in net income&#13;or other comprehensive income under current GAAP. This guidance is effective for fiscal years, and interim periods within those&#13;fiscal years, beginning after December 15, 2011, with early adoption permitted.&amp;#160;&amp;#160;The Company is currently evaluating&#13;this guidance, but does not expect its adoption will have a material effect on its consolidated financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 3 &amp;#150; Furniture &amp;#38; equipment&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Equipment consisted of the following as at September 30, 2012 and&#13;2011:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 11pt; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; font-size: 11pt; font-weight: bold; text-align: center"&gt;September 30, 2012&lt;/td&gt;&#13;    &lt;td style="font-size: 11pt; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; font-size: 11pt; font-weight: bold; text-align: center"&gt;December 31, 2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 48%; vertical-align: top; font-size: 11pt"&gt;Furniture and equipment&lt;/td&gt;&#13;    &lt;td style="width: 4%; vertical-align: top; font-size: 11pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 20%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;9,879&lt;/td&gt;&#13;    &lt;td style="width: 4%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 20%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt"&gt;Computer equipment&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;4,653&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;4,653&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;14,532&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;4,653&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt"&gt;Accumulated depreciation&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;9,559&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;468&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt"&gt;Furniture &amp;#38; equipment net&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; font-weight: bold; text-align: right"&gt;4,973&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; font-weight: bold; text-align: right"&gt;4,185&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the nine months ended September 30, 2012 the Company incurred&#13;depreciation expense of $1,451, (2011 - $416).&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2012-01-01to2012-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 11pt; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; font-size: 11pt; font-weight: bold; text-align: center"&gt;September 30, 2012&lt;/td&gt;&#13;    &lt;td style="font-size: 11pt; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; font-size: 11pt; font-weight: bold; text-align: center"&gt;December 31, 2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 48%; vertical-align: top; font-size: 11pt"&gt;Furniture and equipment&lt;/td&gt;&#13;    &lt;td style="width: 4%; vertical-align: top; font-size: 11pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 20%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;9,879&lt;/td&gt;&#13;    &lt;td style="width: 4%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 20%; vertical-align: bottom; font-size: 11pt; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt"&gt;Computer equipment&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;4,653&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;4,653&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;14,532&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;4,653&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt"&gt;Accumulated depreciation&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;9,559&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;468&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt"&gt;Furniture &amp;#38; equipment net&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 11pt; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; font-weight: bold; text-align: right"&gt;4,973&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 11pt; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-size: 11pt; font-weight: bold; text-align: right"&gt;4,185&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 4 &amp;#150; Intangible Assets&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Intangible assets are comprised of patents, trademarks&amp;#160;and&#13;license rights which are recorded at cost, comprised of legal fees and acquisition costs. Once each patent or trademark is issued,&#13;capitalized costs are amortized on a straight-line basis over a period not to exceed 20 years and 10 years, respectively. License&#13;rights are amortized over the period of the respective license agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 4%; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: center"&gt;September 30, 2012&lt;/td&gt;&#13;    &lt;td style="width: 4%; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top"&gt;Patents&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;2,001,493&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;1,685,867&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top"&gt;Trademarks&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;234,277&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;197,783&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top"&gt;License rights&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;4,214&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-weight: bold; text-align: right"&gt;2,239,984&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-weight: bold; text-align: right"&gt;1,883,650&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;7,597&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top"&gt;Intangibles, net&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: right"&gt;2,232.387&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: right"&gt;1,883,650&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2012-01-01to2012-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 4%; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: center"&gt;September 30, 2012&lt;/td&gt;&#13;    &lt;td style="width: 4%; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top"&gt;Patents&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;2,001,493&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;1,685,867&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top"&gt;Trademarks&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;234,277&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;197,783&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top"&gt;License rights&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;4,214&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-weight: bold; text-align: right"&gt;2,239,984&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-weight: bold; text-align: right"&gt;1,883,650&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;7,597&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top"&gt;Intangibles, net&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: right"&gt;2,232.387&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: right"&gt;1,883,650&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 5 - Cumulative sales of stock:&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt"&gt;Since its inception, we have issued shares of common stock&#13;as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify"&gt;On November 17, 2008, our Directors&#13;authorized the issuance of 7,100,000 founder shares at par value of $0.001. These shares are restricted under rule 144 of the Securities&#13;Exchange Commission.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify"&gt;On various days in December 2008,&#13;our Directors authorized the issuance of 1,776,100 shares of common stock at a price of $0.01 per share as fully paid and non-assessable&#13;to the subscriber. These shares are not restricted and are free trading.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify"&gt;On November 15, 2010, our Directors&#13;initiated a forward stock split of 18:1 and increased the authorized shares from 100,000,000 to 250,000,000&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify"&gt;On December 30, 2010, the Directors&#13;approved the cancellation of 87,800,000 shares of common stock, held by the Director and CEO of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On December 31, 2010, the Directors issued 15,600,000 shares in&#13;conjunction with the acquisition of the agreements to acquire an interest in the 5BARz intellectual property, and hold the exclusive&#13;global sales and marketing rights for the 5BARz products.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the period January to March 2011 the Company issued 650,000&#13;shares of common stock at a price of $1.00 per share for aggregate proceeds of $650,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the period from April 1, 2011 to June 30, 2011 the Company&#13;issued 575,500 shares at prices ranging from $0.70 per share to $ 1.00 per share for aggregate proceeds of $553,500.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the period from July 1, 2011 to September 30, 2011 the Company&#13;issued 134,610 shares at prices ranging from $0.20 per share to $ 1.00. per share for aggregate proceeds of $46,500.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the period from October 1, 2011 to December 31, 2011, the&#13;Company issued 1,080,180 shares at prices ranging from $0.10 per share to $0.15 per share for aggregate proceeds of $128,018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On December 1, 2011 the Company issued 355,695 shares of common&#13;stock at a price of $0.20 per share for conversion of a Convertible Debenture Agreement, dated August 15, 2011 in the principal&#13;amount of &lt;font style="color: black"&gt;Fifty Thousand Euros (&amp;#128;50,000), along with accrued interest thereon&lt;/font&gt;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the period, December 1, 2011 to March 31, 2012, 5BARz AG&#13;sold 78,000 common shares with a par value of 0.01 per share, at a price of CHF 3.00 ($3.26 US) per share, for aggregate proceeds&#13;of 234,000 CHF (US &amp;#150; $250,380). The proceeds received have been credited to additional paid in capital in these consolidated&#13;financial statements.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the period January 1, 2012 to March 31, 2012 the Company&#13;issued 2,136,667 shares at prices ranging from $0.10 to $0.15 per share for proceeds of $ 251,500. These private placements are&#13;exempt from registration pursuant to Regulation S under the securities act of 1934.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the period from January 1, 2012 to March 31, 2012 the Company&#13;settled $155,000 of debt to consultants of the Company by the issuance of shares at a price of $0.10 per share, and issued in aggregate&#13;1,550,000 shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On March 29, 2012 the Company issued 9,000,000 shares to Cellynx&#13;Group, Inc. at the market price of $0.20 per share for payment in full of a 60% interest in the patents and trademarks which comprise&#13;the 5BARz technology. This 9,000,000 share position represents a reciprocal share position held by Cellynx Group, Inc. 5Barz International&#13;Inc.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On March 29, 2012 the Company issued 1,250,000 shares of common&#13;stock to two founders of Cellynx Group, Inc., along with $170,000 in cash for 63,412,638 shares of the capital stock of Cellynx&#13;Group, Inc.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;During the period from April 1, 2012 to June 30, 2012 the&#13;Company issued 2,936,667 shares of common stock at prices ranging from $0.08 to $0.15 per share. Proceeds received for the private&#13;placements are comprised of cash of $39,500 and the settlement of debts for services in the amount of $267,932. In addition, 5BARz&#13;AG sold 2,000 shares of common stock for CHF 6,000 ($6,300USD).&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the period from July 1, 2012 to September 30, 2012 the Company&#13;issued 2,571,388 shares of common stock at prices ranging from $0.03 to $0.20 per share. Proceeds received on the private placements&#13;are comprised of cash in the amount of $122,000, shares issued for services for $50,000 and shares issued on the conversion of&#13;notes equal to $12,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;During the period July 1, 2012 to September 30, 2012, 5BARz&#13;AG sold 12,000 shares of common stock for CHF 36,000 ($37,800USD).&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;On August 14, 2012 and September 4, 2012 the Company entered&#13;into two convertible debenture agreements for $12,000. The Convertible debentures yields interest at a rate of 10% per annum and&#13;are convertible 90 days from the date of inception of the agreement at a rate which is a 25% discount to market. The conversion&#13;rate is capped at a price of $0.15 per share. The convertible debenture matures six months from the date of inception.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;&lt;b&gt;Note 6 - Asset acquisition agreement:&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify"&gt;On December 31, 2010, 5BARz International&#13;Inc. acquired three agreements as follows;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 18px; padding-bottom: 13.15pt; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 37px; padding-bottom: 13.15pt"&gt;(i)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 13.15pt; text-align: justify"&gt;An &amp;#147;Amended and Restated Master Global Marketing and Distribution Agreement.&amp;#148;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-bottom: 13.15pt; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 13.15pt"&gt;(ii)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 13.15pt; text-align: justify"&gt;An &amp;#147;Asset Purchase Agreement&amp;#148;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-bottom: 13.15pt; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 13.15pt"&gt;(iii)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 13.15pt; text-align: justify"&gt;A &amp;#147;Revolving line of credit agreement and security agreement&amp;#148;.&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify"&gt;These agreements with Cellynx Group,&#13;Inc. provide for the exclusive global marketing and distribution of the 5BARz line of products and related accessories and a 50%&#13;ownership interest in the 5BARz intellectual property. In addition, a revolving line of credit facility has been made available&#13;to Cellynx.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify"&gt;On March 29, 2012, the Company and&#13;Cellynx Group Inc. entered into an agreement which provided several amendments to the agreement referred to above. As a result&#13;of those amendments, the following arrangements between the Companies were established;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 10px; padding-bottom: 13.15pt; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 37px; padding-bottom: 13.15pt; font-size: 7pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 13.15pt; font-size: 12pt; text-align: justify"&gt;&lt;font style="font-size: 11pt"&gt;i.&lt;/font&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-size: 11pt"&gt;5BARz International, Inc. acquired a 60% interest in the patents and trademarks held by Cellynx Group Inc., referred to as the &amp;#147;&lt;/font&gt;5BARz&amp;#153;&amp;#148; technology. &lt;font style="font-size: 11pt"&gt;That interest in the technology was acquired for proceeds comprised of 9,000,000 shares of the common stock of the Company, valued at the date of acquisition at $0.20 per share or $1,800,000 USD. The acquisition agreement also clarified that the ownership interest in the intellectual property does represent that proportionate interest in income earned from the intellectual property.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt 0.75in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 10px; padding-bottom: 13.15pt; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 37px; padding-bottom: 13.15pt; font-size: 7pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 13.15pt; font-size: 12pt; text-align: justify"&gt;&lt;font style="font-size: 11pt"&gt;ii.&lt;/font&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-size: 11pt"&gt;The Company agreed to make available to Cellynx Group, Inc a revolving line of credit facility in the amount of $2.2 million dollars of which $668,844 has been advanced as of September 30, 2012. This revolving line of credit facility expires on October 5, 2013. Under the terms of the line of credit facility, the Company has the right to convert amounts due under the facility into common stock of Cellynx, at a conversion rate which is the lesser of a fixed conversion rate of $0.00015 per share or a variable rate which is calculated at 25% of the average lowest three closing bid prices of the Cellynx Group, Inc. common stock for a period which is ten (10) days prior to the date of conversion. This conversion rate was established previously by other parties that have funded Cellynx, and is being matched by 5BARz. At September 30, 2012, the Company had converted $139,200 of the amount due under the revolving line of credit facility for 854,745,971 shares of the capital stock of Cellynx Group, Inc. Cellynx is a consolidated subsidiary of 5Barz International Inc., since March 29, 2012. 5Barz currently holds a 58.6% equity interest in Cellynx Group, Inc.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 10px; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 37px; font-size: 7pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 11pt"&gt;iii.&lt;/font&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-size: 11pt"&gt;Pursuant to the Master Global Marketing and Distribution agreement between 5Barz International Inc and Cellyx Group, Inc., the registrant was obligated to pay to Cellynx Group, Inc a royalty fee amounting to 50% of the Company&amp;#146;s Net Earnings, from products or license arrangements related to the 5BARz technology, in a ratio equal to the Cellynx proportionate interest in that technology. That fee would be paid on a quarterly basis, payable in cash or immediately available funds and shall be due and payable not later than 45 days following the end of each calendar quarter of the year. The asset acquisition agreement amendment referred to herein specified that the royalties would be paid in relation to the ownership of the intellectual property. In addition as a result of the recent acquisition of a 60% interest in Cellynx Group, Inc. by the registrant, this royalty item is an intercompany transaction which in the future will be eliminated upon consolidation in financial reporting of the consolidated financial results of 5BARz International Inc. and subsidiaries.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt"&gt;&lt;b&gt;Note 7 &amp;#150; Options Warrants and Convertible Securities:&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Promissory note&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On September 20, 2011, 5BARz International Inc., (&amp;#147;the Company&amp;#148;),&#13;completed a transaction pursuant to a Promissory Note agreement (the Note), through which the Company borrowed $42,500. The Note&#13;bears interest at a rate of 8%, and is due on June 22, 2012, (the &amp;#147;Due Date&amp;#148;).&amp;#160;&amp;#160;The Company may settle that&#13;note within the first 90 days following the issue date by paying to the&amp;#160;Lender 140% of the principle amount of the note plus&#13;accrued interest. The Company may settle the note during the period which is 91 days from the issue date of the note to 180 days&#13;from the issue date of the note by payment of 150% of the principle amount of the note plus accrued interest. In the event that&#13;the note is not repaid 180 days from the date of issue, the note is convertible into common stock. On March 20, 2012 the note,&#13;along with accrued interest and a prepayment amount was settled by payment of $65,361.52, and the note was cancelled.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On February 27, 2012, 5BARz International Inc., (&amp;#147;the Company&amp;#148;),&#13;completed a transaction pursuant to a Promissory Note agreement (the Note), through which the Company borrowed $37,500. The Note&#13;bears interest at a rate of 8%, and is due on November 29, 2012, (the &amp;#147;Due Date&amp;#148;).&amp;#160;&amp;#160;The Company may settle&#13;that note within the first 90 days following the issue date by paying to the&amp;#160;Lender 140% of the principle amount of the note&#13;plus accrued interest. The Company may settle the note during the period which is 91 days from the issue date of the note to 180&#13;days from the issue date of the note by payment of 150% of the principle amount of the note plus accrued interest. In the event&#13;that the note is not repaid 180 days from the date of issue, the note is convertible into common stock at a variable conversion&#13;price equal to 55% of the average of the three lowest closing bid prices for the Company&amp;#146;s common stock for a period of 10&#13;days prior to the date of notice of conversion. On September 10, 2012, the Company redeemed $12,000 payable on that note, by the&#13;issuance of 401,338 common shares at a price of $0.0299 per share. On September 28, 2012, the company provided written confirmation&#13;of acceptance of an offer to settle the balance of the note and accrued interest by payment of $35,000. That amount is due immediately.&#13;If the Company does not pay that amount, the Company could become involved in a litigation related to the situation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On May 3, 2012, 5BARz International Inc., (&amp;#147;the Company&amp;#148;),&#13;completed a transaction pursuant to a Promissory Note agreement (the Note), through which the Company borrowed $42,500. The proceeds&#13;were received by the Company on May 24, 2012. The Note bears interest at a rate of 8%, and is due on February 3, 2013, (the &amp;#147;Due&#13;Date&amp;#148;).&amp;#160;&amp;#160;The Company may settle that note within the first 90 days following the issue date by paying to the&amp;#160;Lender&#13;140% of the principle amount of the note plus accrued interest. The Company may settle the note during the period which is 91 days&#13;from the issue date of the note to 180 days from the issue date of the note by payment of 150% of the principle amount of the note&#13;plus accrued interest. In the event that the note is not repaid 180 days from the date of issue, the note is convertible into common&#13;stock at a variable conversion price equal to 55% of the average of the three lowest closing bid prices for the Company&amp;#146;s&#13;common stock for a period of 10 days prior to the date of notice of conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On September 18, 2012, The Company completed a transaction pursuant&#13;to a Promissory Note agreement (the Note), through which the Company borrowed $13,500. The Note bears interest at a rate of 8%,&#13;and is due on March 17, 2013, (the &amp;#147;Due Date&amp;#148;).&amp;#160;&amp;#160;The Company may settle that note within the first 90 days&#13;following the issue date by paying to the&amp;#160;Lender 140% of the principle amount of the note plus accrued interest. The Company&#13;may settle the note during the period which is 91 days from the issue date of the note to 180 days from the issue date of the note&#13;by payment of 150% of the principle amount of the note plus accrued interest. In the event that the note is not repaid 180 days&#13;from the date of issue, the note is convertible into common stock at a variable conversion price equal to 55% of the average of&#13;the three lowest closing bid prices for the Company&amp;#146;s common stock for a period of 10 days prior to the date of notice of&#13;conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;b&gt;&lt;u&gt;Securities Purchase Agreements&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Convertible Debenture Agreement &amp;#38; Equity Investment Agreement&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"&gt;&lt;font style="font-size: 11pt; text-underline-style: none"&gt;In&#13;January 2012, the Company negotiated potential agreements for a convertible debenture and an equity investment agreement with a&#13;private investment firm. As contemplated, the convertible debenture agreement provided that the investor could invest up to $500,000&#13;and convert the principal and unpaid interest into a certain number of shares, 180 days from the date of the agreement. The equity&#13;investment agreement provided &lt;/font&gt;to &lt;font style="font-size: 11pt"&gt;Holder the right, from time to time during the term of the&#13;Agreement, to invest in the Company through the purchase of up to $5,000,000 of the Company's Common Stock. Each purchase under&#13;this Agreement was to be made at 150% of the &amp;#147;Volume Weighted Average Price&amp;#148; (VWAP) on the day prior to the day the&#13;investment is made (the &amp;#147;&lt;b&gt;Purchase Price&lt;/b&gt;&amp;#34;). Beginning on the date that is one hundred eighty (180) days following&#13;the Issue Date, Holder shall have the right to purchase Common Stock under this Agreement. Provided the VWAP is above $0.06, Holder&#13;shall purchase a minimum of $50,000 per month beginning two hundred ten (210) days from the Issue Date. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;As at September 30, 2012, the Company had received $150,000 in funding&#13;from the private investment firm. In addition the Company had taken back a $400,000 note receivable from the investment firm under&#13;the terms of the convertible debenture agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On August 2, 2012 and August 13, 2012, the Company received conversion&#13;notices that materially conflict with the parties&amp;#146; negotiations and the terms of the agreement. Based on those and related&#13;communications, the Company has concluded that there has been no meeting of the minds between the Company and the private investment&#13;firm on key provisions of the putative agreements. The Company has offered to repay the amounts invested along with accrued interest&#13;and additional share compensation, but arrived at no settlement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On October 16, 2012, the investment firm filed a complaint in the&#13;federal court for the Northern District of California claiming breach of contract and seeking compensatory damages and alleged&#13;loss of profits of in excess of $2,500,000, based upon their $150,000 investment made under the putative agreements. &lt;i&gt;La Jolla&#13;Cove Investors, Inc. v. 5Barz International, Inc.&lt;/i&gt;, 3:12-CV-5333 (N.D. Cal.). The Company intends to vigorously defend itself&#13;against the plaintiff&amp;#146;s claims. On November 8, 2012, the Company filed an answer, affirmative defenses, and counterclaims,&#13;against the plaintiff.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Based on its analysis of the facts known at this time, the Company&#13;has recorded no contingent liability with respect to the disagreement. The Company has recorded the $150,000 as a current liability&#13;along with interest calculated at a rate of 8% per annum. The Company will seasonably update this disclosure to reflect any material&#13;developments relating to this situation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Convertible Debentures&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On August 14, 2012 and September 4, 2012 the Company entered&#13;into two convertible debenture agreements for proceeds of $12,000. The Convertible debentures yields interest at a rate of 10%&#13;per annum and are convertible 90 days from the date of inception of the agreement at a rate which is a 25% discount to market.&#13;The conversion rate is capped at a price of $0.15 per share. The convertible debenture matures six months from the date of inception.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Cellynx Group, Inc. &amp;#150; Convertible Promissory Notes&amp;#160;&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The Company&amp;#146;s subsidiary, Cellynx Group, Inc. has two convertible&#13;promissory notes outstanding at September 30, 2012 as follows;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 22%; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Issue Date&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: bottom; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; vertical-align: top; font-weight: bold; text-decoration: underline; text-align: center"&gt;Principal Amount&lt;/td&gt;&#13;    &lt;td style="width: 18%; vertical-align: top; font-weight: bold; text-decoration: underline; text-align: center"&gt;Date of Maturity&lt;/td&gt;&#13;    &lt;td style="width: 3%; vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: top; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Accrued&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Interest&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: top; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Beneficial&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Conversion&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Factor&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: top; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&lt;u&gt;Principle due&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&lt;u&gt;September 30, 2012&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="vertical-align: top"&gt;May 24, 2012&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;37,500 (1)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;February 18, 2013&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;1,060&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 9pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;37,048&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;37,500&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: White"&gt;&#13;    &lt;td style="vertical-align: top"&gt;September 18, 2012&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;12,500 (2)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;June 15, 2013&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;49&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 9pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;12,057&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;12,500&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The notes incur interest at a rate of 8% per annum.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 6px; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 42px"&gt;(1&amp;#38; 2)&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The terms of these note are such that subsequent to the prepayment&#13;        date six months after the issue date, if not paid,&amp;#160;holder may convert principal and unpaid interest on the note into shares&#13;        of the Company&amp;#146;s common stock, with the number of shares issuable determined to be the variable conversion factor. The variable&#13;        conversion factor is calculated by dividing the amount to be converted by the conversion price which is equal to 51% of the average&#13;        of the three lowest closing bid prices of the Company&amp;#146;s common stock over the ten trading days prior to the date of the conversion.&#13;        Holder is prohibited from converting amounts if principal and interest that would result in holder receiving shares, which when&#13;        combined with shares of the Company&amp;#146;s common stock held, would result in investor holding more than 4.99% of the Company&amp;#146;s&#13;        then- outstanding common stock. The shares of common stock, if any, issued upon conversion, will be restricted securities as defined&#13;        pursuant to the terms of Rule 144.&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;The Company has the right to pre-pay&#13;the debt up to six months from the date of issue. During the first 120 days following the issue date of the Note may be settled&#13;by paying 150% of the then-outstanding principal amount and any accrued and unpaid interest, penalties, or other amounts owing.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;The Company determined that the notes&#13;contain a beneficial conversion feature because the conversion rate is less than the share price. In addition, the Company records&#13;a debt discount related to the interest rate in the note differential from fair market value interest for the Company, which is&#13;amortized over the term of the loan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On July 9, 2012 the Company paid out a convertible debenture owed&#13;by its subsidiary Company, Cellynx Group, Inc. on the six month anniversary of the note for proceeds of $30,582. The payment represents&#13;payment in full of principle, interest at a rate of 8% per annum and a pre-payment penalty of $14,400.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;u&gt;Cellynx Group Inc. - Options and Warrants&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;At September 30, 2012 Cellynx Group Inc. has the following Options&#13;and Warrants outstanding;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The number and weighted average exercise prices&#13;of all options exercisable as of September 30, 2012, are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1pt solid; font-size: 10pt; text-align: center"&gt;Options Exercisable&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Range of&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number Outstanding as of&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;September 30, 2012&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Remaining Contractual&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Life (Years)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;0.0006&lt;/td&gt;&#13;    &lt;td style="width: 3%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 25%; text-align: right"&gt;12,500,000&lt;/td&gt;&#13;    &lt;td style="width: 2%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;0.0006&lt;/td&gt;&#13;    &lt;td style="width: 4%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;4.72&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.001&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2,500,000&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.001&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2.44&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.10 - 0.25&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;21,554,757&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.17&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.20&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.26 - 4.00&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right"&gt;2,000,000&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2.00&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;.17&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 2.25pt double; padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 2.25pt double; padding-bottom: 2.25pt; text-align: right"&gt;38,554,757&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Warrants&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the warrant&#13;activity:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number of&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Average Remaining&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Contractual Life&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Aggregate&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Intrinsic Value&lt;/p&gt;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;Outstanding at December 31, 2011&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;42,514,757&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;0.12&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;Granted&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;Exercised&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;Expired&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;10,060,000&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 43%; padding-bottom: 2.25pt"&gt;Outstanding at September 30, 2012&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;32,454,757&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;0.27&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; padding-bottom: 2.25pt; text-align: center"&gt;.88&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 2.25pt double; text-align: center"&gt;0&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.25pt"&gt;Exercisable at September 30, 2012&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;32,454,457&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;0.27&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: center"&gt;.88&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: center"&gt;0&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 13.15pt"&gt;&lt;b&gt;Note 8 &amp;#150; Related party transactions&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On December 30, 2010 the Company acquired by way of an assignment&#13;agreement all right title and interest in a set of agreements from a Company of which the President and Director is also the President&#13;and Director of the reporting Company. The proceeds to be paid for that assignment agreement is comprised of a note payable in&#13;the amount of $370,000, and the issuance of 15,600,000 shares of common stock.&amp;#160;&amp;#160;During the nine months ended September&#13;30, 2012 the Company paid $67,494 of principle and interest on that note. At September 30, 2012 the Company had a remaining balance&#13;on that note payable in the amount of Nil (December 31, 2011 - $30,618 ). The note payable accrued interest at a rate of 5% per&#13;annum, and during the nine months ended September 30, 2012, interest in the amount of $115 was charged pursuant to the terms of&#13;this note.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;In addition, at September 30, 2012 the Company had an amount due&#13;to that related party comprised of payments made by the related party on behalf of the Company aggregating $22,825 (December 31,&#13;2011 - $79,803). That amount due is non interest bearing and has no specific terms of repayment.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 9 &amp;#150; Investment in 5BARz AG&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On October 6, 2011, the Company commenced the organization of a&#13;subsidiary Company under the laws of Switzerland, in the Canton of Zurich, called 5BARz AG. 5BARz AG issued 10,000,000 common shares&#13;of which 5,100,000 are held by the Company, 450,000 are held by officers and a consultant to the Company and 4,450,000 were held&#13;in escrow for resale, by an independent escrow agent under the control of the Company. 5BARz AG issued the shares with a stated&#13;or par value of CHF 0.01 per share for proceeds of CHF 100,000 (US - $108,752). The net proceeds received on re-sale above the&#13;stated or par value of the shares, is paid into 5Barz AG as additional paid in capital.&lt;b&gt; &lt;/b&gt;During the nine months ended September&#13;30, 2012, sales of those securities aggregated 71,000 shares sold for proceeds of $213,000 CHF ($223,650 USD). At September 30,&#13;2012 the Company holds a 94.6% controlling interest in 5BArz AG represented by 9,458,000 shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On October 19, 2011, the registrant, 5BARz International Inc. entered&#13;into a Marketing and Distribution agreement with 5BARz AG, through which 5BARz AG holds the exclusive rights for the marketing&#13;and distribution of products produced under the 5BARz&lt;b&gt; &lt;/b&gt;brand for markets in Switzerland, Austria and Germany. That agreement&#13;does not have a royalty payment requirement, and remains effective as long as 5BARz Ag is controlled by the Company. 5BARz Ag is&#13;a consolidated subsidiary of the Company in these financial statements.&lt;/p&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 10 &amp;#150; Investment in Cellynx Group, Inc.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On January 7, 2011 the Company entered into a stock purchase agreement&#13;with two founding shareholders of Cellynx Group, Inc. to acquire in aggregate 63,412,638 shares of the capital stock of Cellynx&#13;Group, Inc. for total proceeds of $634,126. At that date the Company had paid $170,000 as a deposit made under that agreement.&#13;On March 29, 2012 the Company entered into a securities exchange agreement and settlement agreement with each of the two founding&#13;shareholders of Cellynx Group, Inc. whereby in addition to the $170,000 paid, the Company issued 1,250,000 shares of common stock&#13;of the issuer in exchange for the 63,412,638 shares of Cellynx Group, Inc. and mutual releases were signed between the parties&#13;releasing each from any further obligation.&lt;/p&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 11 &amp;#150; Business combination&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On March 29, 2012, the Company acquired a 60% interest in Cellynx&#13;Group, Inc. a Company based in California, which was the owner of the 5BARz intellectual property and is in the business of the&#13;development and commercialization of that technology. The objective of the acquisition is to integrate the global commercialization&#13;of the 5BARz technology and products, into a combined business and operating strategy. The purchase price at the acquisition date,&#13;which was settled in cash, shares, and the settlement of convertible debt was $875,000, as follows;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 4%; vertical-align: top; text-align: right"&gt;i.&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 75%; vertical-align: top"&gt;Cash consideration paid&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 13%; vertical-align: bottom; text-align: right"&gt;170,000&lt;/td&gt;&#13;    &lt;td style="width: 4%; vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;ii.&lt;/td&gt;&#13;    &lt;td style="font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;1,250,000 common shares of the registrant issued at a market price of $0.20 per share&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;250,000&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;iii.&lt;/td&gt;&#13;    &lt;td style="font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;Redemption of convertible debt for 350 million shares of Cellynx Group Inc. common stock&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;455,000&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;(a)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;Fair market value of consideration paid&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt; 875,000&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 18px; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18px"&gt;(a)&lt;/td&gt;&#13;    &lt;td&gt;The valuation of the debt instrument with an embedded conversion feature is calculated at the face value of the debt instrument of $73,500 plus the intrinsic value attributable to the conversion of the debt instrument at a 75% discount to market, based upon the lowest 3 closing bid prices of the common stock for a period of 30 days prior to the date of conversions. That intrinsic valuation is calculated to be $ 381,500.&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;The amounts recognized for each class of the acquire&amp;#146;s assets&#13;and liabilities recognized at the acquisition date, March 29, 2012 are as follows;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border: black 1pt solid; font-weight: bold"&gt;Description&lt;/td&gt;&#13;    &lt;td colspan="2" style="border: black 1pt solid; font-weight: bold; text-align: center"&gt;Net book value of Cellynx Group, Inc. consolidated assets and liabilities&lt;/td&gt;&#13;    &lt;td colspan="2" style="border: black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustments (i)&lt;/td&gt;&#13;    &lt;td colspan="2" style="border: black 1pt solid; font-weight: bold; text-align: center"&gt;Valuation attributed to assets acquired&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 36%; vertical-align: top; border: black 1pt solid"&gt;Current assets&lt;/td&gt;&#13;    &lt;td style="width: 6%; vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 14%; vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;3,260&lt;/td&gt;&#13;    &lt;td style="width: 6%; vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 7%; vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 14%; vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;3,260&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Patents, trademarks, and license&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;44,718&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;44,718&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Investment in 5BARz&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,800,000&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,800,000&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Furniture and equipment&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;2,113&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;2,113&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Accounts payable and accruals&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,735,112&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,735,112&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Notes payable (net of discount)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;368,411&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;368,411&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Beneficial conversion liability&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;5,856,633&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;(5,621,027)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;235,606&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;LOC payable &amp;#150; 5BARz (net)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;514,745&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;( 514,745)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Net book value of assets acquired&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;(6,624,810)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;(6,135,772)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;(489,038)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Goodwill&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,364,038&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Purchase price&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;875,000&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 10px; font-size: 12pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10px; font-family: Calibri, Helvetica, Sans-Serif"&gt;(i)&lt;/td&gt;&#13;    &lt;td style="font-family: Calibri, Helvetica, Sans-Serif"&gt;In determining the NBV of assets acquired, the Company wrote off the convertible debt owed to the acquirer and the beneficial conversion liability attributed to that debt.&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="color: black"&gt;The individual results of operation for&#13;Cellynx Group Inc. for the quarter ended June 30, 2012 are available at the web site &lt;/font&gt;www.sec.gov&lt;font style="color: black"&gt;,&#13;as that entity is a reporting public company, trading on the OTCBB in the US under trading symbol &amp;#147;CYNX&amp;#148;.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Subsequent to the date of acquisition, 5Barz International Inc.&#13;converted two amounts of debt due from Cellynx Group Inc.. On April 13, 2012 the company converted $7,700 of debt in exchange for&#13;51,333,333 shares of Cellynx and on May 15, 2012 5Barz converted $58,500 dollars of debt due from Cellynx for 390,000,000 shares&#13;of Cellynx. &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock contextRef="From2012-01-01to2012-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 4%; vertical-align: top; text-align: right"&gt;i.&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 75%; vertical-align: top"&gt;Cash consideration paid&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 13%; vertical-align: bottom; text-align: right"&gt;170,000&lt;/td&gt;&#13;    &lt;td style="width: 4%; vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;ii.&lt;/td&gt;&#13;    &lt;td style="font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;1,250,000 common shares of the registrant issued at a market price of $0.20 per share&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;250,000&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;iii.&lt;/td&gt;&#13;    &lt;td style="font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;Redemption of convertible debt for 350 million shares of Cellynx Group Inc. common stock&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;455,000&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: windowtext 1pt solid; text-align: right"&gt;(a)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;Fair market value of consideration paid&lt;/td&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt; 875,000&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2012-01-01to2012-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border: black 1pt solid; font-weight: bold"&gt;Description&lt;/td&gt;&#13;    &lt;td colspan="2" style="border: black 1pt solid; font-weight: bold; text-align: center"&gt;Net book value of Cellynx Group, Inc. consolidated assets and liabilities&lt;/td&gt;&#13;    &lt;td colspan="2" style="border: black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustments (i)&lt;/td&gt;&#13;    &lt;td colspan="2" style="border: black 1pt solid; font-weight: bold; text-align: center"&gt;Valuation attributed to assets acquired&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 36%; vertical-align: top; border: black 1pt solid"&gt;Current assets&lt;/td&gt;&#13;    &lt;td style="width: 6%; vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 14%; vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;3,260&lt;/td&gt;&#13;    &lt;td style="width: 6%; vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 7%; vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 14%; vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;3,260&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Patents, trademarks, and license&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;44,718&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;44,718&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Investment in 5BARz&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,800,000&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,800,000&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Furniture and equipment&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;2,113&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;2,113&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Accounts payable and accruals&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,735,112&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,735,112&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Notes payable (net of discount)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;368,411&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;368,411&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Beneficial conversion liability&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;5,856,633&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;(5,621,027)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;235,606&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;LOC payable &amp;#150; 5BARz (net)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;514,745&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;( 514,745)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Net book value of assets acquired&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;(6,624,810)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;(6,135,772)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;(489,038)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Goodwill&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;1,364,038&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; border: black 1pt solid"&gt;Purchase price&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: right"&gt;875,000&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2012-01-01to2012-09-30">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 12 &amp;#150; Subsequent events&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Sales of Common Stock&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;On October 12, 2012 the Company issued 300,000 shares at a price&#13;of $0.05 per share for proceeds of $15,000. The shares have been issued pursuant to a Regulation &amp;#147;S&amp;#148; exemption from&#13;registration under the Securities and Exchange Act of 1934.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;In October 26, 2012 the Company issued 100,000 shares at a price&#13;of $0.05 per share for proceeds of $5,000. The shares have been issued pursuant to a Regulation &amp;#147;S&amp;#148; exemption from&#13;registration under the Securities and Exchange Act of 1934.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2012-01-01to2012-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 22%; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Issue Date&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: bottom; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; vertical-align: top; font-weight: bold; text-decoration: underline; text-align: center"&gt;Principal Amount&lt;/td&gt;&#13;    &lt;td style="width: 18%; vertical-align: top; font-weight: bold; text-decoration: underline; text-align: center"&gt;Date of Maturity&lt;/td&gt;&#13;    &lt;td style="width: 3%; vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: top; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Accrued&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Interest&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: top; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Beneficial&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Conversion&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;u&gt;Factor&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; vertical-align: top; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&lt;u&gt;Principle due&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;b&gt;&lt;u&gt;September 30, 2012&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="vertical-align: top"&gt;May 24, 2012&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;37,500 (1)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;February 18, 2013&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;1,060&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 9pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;37,048&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;37,500&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: White"&gt;&#13;    &lt;td style="vertical-align: top"&gt;September 18, 2012&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;12,500 (2)&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;June 15, 2013&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font-size: 9pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;49&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 9pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;12,057&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 9pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;12,500&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="From2012-01-01to2012-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1pt solid; font-size: 10pt; text-align: center"&gt;Options Exercisable&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Range of&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number Outstanding as of&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;September 30, 2012&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Remaining Contractual&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Life (Years)&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;0.0006&lt;/td&gt;&#13;    &lt;td style="width: 3%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 25%; text-align: right"&gt;12,500,000&lt;/td&gt;&#13;    &lt;td style="width: 2%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;0.0006&lt;/td&gt;&#13;    &lt;td style="width: 4%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;4.72&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.001&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2,500,000&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.001&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2.44&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.10 - 0.25&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;21,554,757&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.17&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.20&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: right"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0.26 - 4.00&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right"&gt;2,000,000&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2.00&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;.17&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 2.25pt double; padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 2.25pt double; padding-bottom: 2.25pt; text-align: right"&gt;38,554,757&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2012-01-01to2012-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Number of&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Weighted Average&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: windowtext 1pt solid; padding-bottom: 1.1pt"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Average Remaining&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Contractual Life&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 1.1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Aggregate&lt;/p&gt;&#13;        &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Intrinsic Value&lt;/p&gt;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;Outstanding at December 31, 2011&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;42,514,757&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;0.12&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;Granted&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;Exercised&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;Expired&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;10,060,000&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#151;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 43%; padding-bottom: 2.25pt"&gt;Outstanding at September 30, 2012&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;32,454,757&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;0.27&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; padding-bottom: 2.25pt; text-align: center"&gt;.88&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 2.25pt double; text-align: center"&gt;0&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.25pt"&gt;Exercisable at September 30, 2012&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;32,454,457&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; padding-bottom: 2.25pt; text-align: center"&gt;0.27&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.25pt; text-align: center"&gt;.88&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2.25pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: center"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: center"&gt;0&lt;/td&gt;&#13;    &lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2012-01-01to2012-09-30_Note2Member" unitRef="Shares" decimals="INF">401338</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2012-09-30_Note2Member" unitRef="USDPShares" decimals="INF">0.0299</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2012-09-30_DebtSecuritiesMember" unitRef="USDPShares" decimals="INF">0.15</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2012-09-30_Note2Member" unitRef="USD" decimals="0">35000</us-gaap:InterestPayableCurrent>
    <us-gaap:AccountsPayableInterestBearingCurrent contextRef="AsOf2012-09-30_CellynxNote1Member" unitRef="USD" decimals="0">1060</us-gaap:AccountsPayableInterestBearingCurrent>
    <us-gaap:AccountsPayableInterestBearingCurrent contextRef="AsOf2012-09-30_CellynxNote2Member" unitRef="USD" decimals="0">49</us-gaap:AccountsPayableInterestBearingCurrent>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2012-01-01to2012-09-30_CellynxNote1Member" unitRef="USD" decimals="0">37048</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2012-01-01to2012-09-30_CellynxNote2Member" unitRef="USD" decimals="0">12057</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <BARZOB:DebtInstrumentIssuanceDateAdditional contextRef="From2012-07-01to2012-09-30_DebtSecuritiesMember">2012-09-04</BARZOB:DebtInstrumentIssuanceDateAdditional>
    <us-gaap:DebtInstrumentMaturityDateDescription contextRef="From2012-07-01to2012-09-30_DebtSecuritiesMember" id="Foot-02-0">90 days</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:LossContingencyDamagesSoughtValue contextRef="From2012-01-01to2012-09-30_InvestorMember" unitRef="USD" decimals="0">2500000</us-gaap:LossContingencyDamagesSoughtValue>
    <BARZOB:ConvertibleDebentureIssuedToInvestor contextRef="AsOf2012-09-30_InvestorMember" unitRef="USD" decimals="0">150000</BARZOB:ConvertibleDebentureIssuedToInvestor>
    <BARZOB:NoteReceivableExchangeForConvertibleDebenture contextRef="From2012-01-01to2012-09-30_InvestorMember" unitRef="USD" decimals="0">400000</BARZOB:NoteReceivableExchangeForConvertibleDebenture>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2012-09-30_InvestorMember" unitRef="Pure" decimals="INF">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <BARZOB:ConvertibleDebentureAgreement contextRef="AsOf2012-01-31_InvestorMember" unitRef="USD" decimals="0">500000</BARZOB:ConvertibleDebentureAgreement>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="From2012-07-01to2012-07-09_ConvertibleDebtMember" unitRef="USD" decimals="0">30582</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleInterestExpense contextRef="From2012-07-01to2012-07-09_ConvertibleDebtMember" unitRef="USD" decimals="0">14400</us-gaap:DebtInstrumentConvertibleInterestExpense>
    <BARZOB:BarzAgCommonStockIssuedHeldByOfficersAndConsultantShares contextRef="From2011-10-01to2011-10-06_SubsidiariesMember" unitRef="Shares" decimals="INF">450000</BARZOB:BarzAgCommonStockIssuedHeldByOfficersAndConsultantShares>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-02" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-03" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">That fee would be paid on a quarterly basis, payable in cash or immediately available funds and shall be due and payable not later than 45 days following the end of each calendar quarter of the year.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">25% of average lowest three closing bid prices of Cellynx Group, Inc. common stock for a period which is ten (10) days prior to the date of conversion.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">Convertible 90 days from the date of inception of the agreement at a rate which is a 25% discount to market.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
